Inhibition of cell migration by focal adhesion kinase: Time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells

Yu,Hongchi; Gao,Min; Ma,Yunlong; Wang,Lijuan; Shen,Yang; Liu,Xiaoheng

doi:10.3892/ijmm.2018.3512

Inhibition of cell migration by focal adhesion kinase: Time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells

Authors:
- Hongchi Yu
- Min Gao
- Yunlong Ma
- Lijuan Wang
- Yang Shen
- Xiaoheng Liu
View Affiliations

Affiliations: Institute of Biomedical Engineering, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: February 23, 2018 https://doi.org/10.3892/ijmm.2018.3512
Pages: 2573-2588
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

angiogenesis plays an important role in the development and progression of tumors, and it involves a series of signaling pathways contributing to the migration of endothelial cells for vascularization and to the invasion of cancer cells for secondary tumor formation. Among these pathways, the focal adhesion kinase (FAK) signaling cascade has been implicated in a variety of human cancers in connection with cell adhesion and migration events leading to tumor angiogenesis, metastasis and invasion. Therefore, the inhibition of FAK in endothelial and/or cancer cells is a potential target for anti‑angiogenic therapy. In the present study, a small‑molecule FAK inhibitor, 1,2,4,5-benzenetetramine tetrahydrochloride (Y15), was used to study the effects of FAK inhibition on the adhesion and migration behaviors of vascular endothelial cells (VECs) and human hepatoblastoma cells. Furthermore, the time-dependent differences in proteins associated with the integrin-mediated FAK/Rho GTPases signaling pathway within 2 h were examined. The results indicated that the inhibition of FAK significantly decreased the migration ability of VECs and human hepatoblastoma cells in a dose-dependent manner. Inhibition of FAK promoted cell detachment by decreasing the expression of focal adhesion components, and blocked cell motility by reducing the level of Rho GTPases. However, the expression of crucial proteins involved in integrin-induced signaling in two cell lines exhibited a time-dependent difference with increased duration of FAK inhibitor treatment, suggesting different mechanisms of FAK-mediated cell migration behavior. These results suggest that the mechanism underlying FAK-mediated adhesion and migration behavior differs among various cells, which is expected to provide evidence for future FAK therapy targeted against tumor angiogenesis.

View Figures

View References

1	Weis SM and Cheresh DA: Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 17:1359–1370. 2011. View Article : Google Scholar : PubMed/NCBI
2	Lamalice L, Le Boeuf F and Huot J: Endothelial cell migration during angiogenesis. Circ Res. 100:782–794. 2007. View Article : Google Scholar : PubMed/NCBI
3	Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 3:362–374. 2003. View Article : Google Scholar : PubMed/NCBI
4	Baker EL and Zaman MH: The biomechanical integrin. J Biomech. 43:38–44. 2010. View Article : Google Scholar :
5	Pasapera AM, Schneider IC, Rericha E, Schlaepfer DD and Waterman CM: Myosin II activity regulates vinculin recruitment to focal adhesions through FAK-mediated paxillin phosphorylation. J Cell Biol. 188:877–890. 2010. View Article : Google Scholar : PubMed/NCBI
6	Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, et al: Differential regulation of cell motility and invasion by FAK. J Cell Biol. 160:753–767. 2003. View Article : Google Scholar : PubMed/NCBI
7	Thamilselvan V, Craig DH and Basson MD: FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J. 21:1730–1741. 2007. View Article : Google Scholar : PubMed/NCBI
8	Gurney SM, Forster P, Just U and Schwanbeck R: Suppression of the PI3K subunit p85α delays embryoid body development and inhibits cell adhesion. J Cell Biochem. 112:3573–3581. 2011. View Article : Google Scholar : PubMed/NCBI
9	Clark EA, King WG, Brugge JS, Symons M and Hynes RO: Integrin-mediated signals regulated by members of the Rho family of GTPases. J Cell Biol. 142:573–586. 1998. View Article : Google Scholar : PubMed/NCBI
10	Raftopoulou M and Hall A: Cell migration: Rho GTPases lead the way. Dev Biol. 265:23–32. 2004. View Article : Google Scholar
11	Tavora B, Batista S, Reynolds LE, Jadeja S, Robinson S, Kostourou V, Hart I, Fruttiger M, Parsons M and Hodivala-Dilke KM: Endothelial FAK is required for tumour angiogenesis. EMBO Mol Med. 2:516–528. 2010. View Article : Google Scholar : PubMed/NCBI
12	Zhao X and Guan JL: Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev. 63:610–615. 2011. View Article : Google Scholar :
13	Yom CK, Noh DY, Kim WH and Kim HS: Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer. Breast Cancer Res Treat. 128:647–655. 2011. View Article : Google Scholar
14	Miyazaki T, Kato H, Nakajima M, Sohda M, Fukai Y, Masuda N, Manda R, Fukuchi M, Tsukada K and Kuwano H: FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer. 89:140–145. 2003. View Article : Google Scholar : PubMed/NCBI
15	Zhao J and Guan JL: Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev. 28:35–49. 2009. View Article : Google Scholar : PubMed/NCBI
16	Wozniak MA, Modzelewska K, Kwong L and Keely PJ: Focal adhesion regulation of cell behavior. Biochim Biophys Acta. 1692:103–119. 2004. View Article : Google Scholar : PubMed/NCBI
17	Schlaepfer DD and Mitra SK: Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev. 14:92–101. 2004. View Article : Google Scholar : PubMed/NCBI
18	Lu ZJ, Ren YQ, Wang GP, Song Q, Li M, Jiang SS, Ning T, Guan YS, Yang JL and Luo F: Biological behaviors and proteomics analysis of hybrid cell line EAhy926 and its parent cell line A549. J Exp Clin Cancer Res. 28:162009. View Article : Google Scholar : PubMed/NCBI
19	Golubovskaya VM, Nyberg C, Zheng M, Kweh F, Magis A, Ostrov D and Cance WG: A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. J Med Chem. 51:7405–7416. 2008. View Article : Google Scholar : PubMed/NCBI
20	Moissoglu K and Schwartz MA: Integrin signalling in directed cell migration. Biol Cell. 98:547–555. 2006. View Article : Google Scholar : PubMed/NCBI
21	Ezzell RM, Goldmann WH, Wang N, Parashurama N and Ingber DE: Vinculin promotes cell spreading by mechanically coupling integrins to the cytoskeleton. Exp Cell Res. 231:14–26. 1997. View Article : Google Scholar : PubMed/NCBI
22	Engelman JA: Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer. 9:550–562. 2009. View Article : Google Scholar : PubMed/NCBI
23	Ridley AJ: Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16:522–529. 2006. View Article : Google Scholar : PubMed/NCBI
24	Schwarz J, Proff J, Hävemeier A, Ladwein M, Rottner K, Barlag B, Pich A, Tatge H, Just I and Gerhard R: Serine-71 phosphorylation of Rac1 modulates downstream signaling. PLoS One. 7:e443582012. View Article : Google Scholar : PubMed/NCBI
25	Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT and De Bruijn EA: Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 56:549–580. 2004. View Article : Google Scholar : PubMed/NCBI
26	Unger RE, Krump-Konvalinkova V, Peters K and Kirkpatrick CJ: In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res. 64:384–397. 2002. View Article : Google Scholar : PubMed/NCBI
27	Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH and Schlaepfer DD: FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol. 2:249–256. 2000. View Article : Google Scholar : PubMed/NCBI
28	Braren R, Hu H, Kim YH, Beggs HE, Reichardt LF and Wang R: Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol. 172:151–162. 2006. View Article : Google Scholar : PubMed/NCBI
29	van Nimwegen MJ, Verkoeijen S, van Buren L, Burg D and van de Water B: Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res. 65:4698–4706. 2005. View Article : Google Scholar : PubMed/NCBI
30	McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer. 5:505–515. 2005. View Article : Google Scholar : PubMed/NCBI
31	Beierle EA, Ma X, Stewart J, Nyberg C, Trujillo A, Cance WG and Golubovskaya VM: Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma. Cell Cycle. 9:1005–1015. 2010. View Article : Google Scholar : PubMed/NCBI
32	Hochwald SN, Nyberg C, Zheng M, Zheng D, Wood C, Massoll NA, Magis A, Ostrov D, Cance WG and Golubovskaya VM: A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer. Cell Cycle. 8:2435–2443. 2009. View Article : Google Scholar : PubMed/NCBI
33	Infusino GA and Jacobson JR: Endothelial FAK as a therapeutic target in disease. Microvasc Res. 83:89–96. 2012. View Article : Google Scholar
34	Golubovskaya VM and Cance W: Focal adhesion kinase and p53 signal transduction pathways in cancer. Front Biosci (Landmark Ed). 15:901–912. 2010. View Article : Google Scholar
35	Lim ST, Mikolon D, Stupack DG and Schlaepfer DD: FERM control of FAK function: implications for cancer therapy. Cell Cycle. 7:2306–2314. 2008. View Article : Google Scholar : PubMed/NCBI
36	Eleniste PP and Bruzzaniti A: Focal adhesion kinases in adhesion structures and disease. J Signal Transduct. 2012:2964502012. View Article : Google Scholar : PubMed/NCBI
37	Zheng Y and Lu Z: Paradoxical roles of FAK in tumor cell migration and metastasis. Cell Cycle. 8:3474–3479. 2009. View Article : Google Scholar : PubMed/NCBI
38	Yano H, Mazaki Y, Kurokawa K, Hanks SK, Matsuda M and Sabe H: Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion. J Cell Biol. 166:283–295. 2004. View Article : Google Scholar : PubMed/NCBI
39	Hauck CR, Sieg DJ, Hsia DA, Loftus JC, Gaarde WA, Monia BP and Schlaepfer DD: Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res. 61:7079–7090. 2001.PubMed/NCBI
40	Lu Z, Jiang G, Blume-Jensen P and Hunter T: Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol. 21:4016–4031. 2001. View Article : Google Scholar : PubMed/NCBI
41	Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L and Tripodi M: TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res. 314:143–152. 2008. View Article : Google Scholar
42	Kallergi G, Agelaki S, Markomanolaki H, Georgoulias V and Stournaras C: Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells. Cell Physiol Biochem. 20:977–986. 2007. View Article : Google Scholar : PubMed/NCBI
43	Tadokoro S, Shattil SJ, Eto K, Tai V, Liddington RC, de Pereda JM, Ginsberg MH and Calderwood DA: Talin binding to integrin beta tails: a final common step in integrin activation. Science. 302:103–106. 2003. View Article : Google Scholar : PubMed/NCBI
44	Baumann K: Cell adhesion: FAK or talin: who goes first. Nat Rev Mol Cell Biol. 13:138–139. 2012.
45	Zaidel-Bar R, Milo R, Kam Z and Geiger B: A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions. J Cell Sci. 120:137–148. 2007. View Article : Google Scholar
46	Lawson C, Lim ST, Uryu S, Chen XL, Calderwood DA and Schlaepfer DD: FAK promotes recruitment of talin to nascent adhesions to control cell motility. J Cell Biol. 196:223–232. 2012. View Article : Google Scholar : PubMed/NCBI
47	Weis SM, Lim ST, Lutu-Fuga KM, Barnes LA, Chen XL, Göthert JR, Shen TL, Guan JL, Schlaepfer DD and Cheresh DA: Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK. J Cell Biol. 181:43–50. 2008. View Article : Google Scholar : PubMed/NCBI
48	Lim Y, Lim ST, Tomar A, Gardel M, Bernard-Trifilo JA, Chen XL, Uryu SA, Canete-Soler R, Zhai J, Lin H, et al: PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility. J Cell Biol. 180:187–203. 2008. View Article : Google Scholar : PubMed/NCBI
49	Schaller MD: Paxillin: a focal adhesion-associated adaptor protein. Oncogene. 20:6459–6472. 2001. View Article : Google Scholar : PubMed/NCBI
50	Xia H, Nho RS, Kahm J, Kleidon J and Henke CA: Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway. J Biol Chem. 279:33024–33034. 2004. View Article : Google Scholar : PubMed/NCBI
51	Reiske HR, Kao SC, Cary LA, Guan JL, Lai JF and Chen HC: Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration. J Biol Chem. 274:12361–12366. 1999. View Article : Google Scholar : PubMed/NCBI
52	Myers JP, Robles E, Ducharme-Smith A and Gomez TM: Focal adhesion kinase modulates Cdc42 activity downstream of positive and negative axon guidance cues. J Cell Sci. 125:2918–2929. 2012. View Article : Google Scholar : PubMed/NCBI
53	Ren XD, Kiosses WB, Sieg DJ, Otey CA, Schlaepfer DD and Schwartz MA: Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J Cell Sci. 113:3673–3678. 2000.PubMed/NCBI